Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

INTRODUCTION: Plasma amyloid β (Aβ) peptides have been previously studied as candidate biomarkers to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. METHODS: Free and total Aβ42/40 plasma ratios (FP42/40 and TP42/40, respectively) were determined...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Alzheimers Dement (Amst)
Autori principali: Fandos, Noelia, Pérez-Grijalba, Virginia, Pesini, Pedro, Olmos, Salvador, Bossa, Matías, Villemagne, Victor L., Doecke, James, Fowler, Christopher, Masters, Colin L., Sarasa, Manuel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
Blood-Based Biomarkers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5602863/
https://ncbi.nlm.nih.gov/pubmed/28948206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.07.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi